GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

While the initial results are promising, more research is needed before the urine test is available to the public. The Cambridge team plans to conduct animal studies and eventually clinical trials ...

Actual results may differ materially from those expressed or implied ... our intention to complete share repurchases under our normal course issuer bid program, including the funding of such share ...